Managingip.com18h
Weighing ‘reasonable expectation of success’ in drug patent inventiveness assessments in China
Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical ...
Managingip.com5h
‘Obvious gap to fill’: IP committee head on importance of representation
David Parrish expects AI to be among the major talking points for a newly formed committee aimed at protecting the interests ...
Managingip.com18h
AI is transforming life sciences but raising risk concerns, new benchmark report finds
A new survey by Arnold & Porter reveals that AI adoption in life sciences is accelerating, driving innovation in drug ...
Managingip.com1d
HSF and Kramer Levin join forces in latest transatlantic merger
The tie-up, which will create a firm with a combined revenue of around $2bn, will add around 10 US-based partners to Herbert ...
Managingip.com2d
KWM: ‘Non-commission-driven’ structure breeds IP success
Maohua Wang, head of the IP group at King & Wood Mallesons in China, explains how the firm’s Eversheds deal affected the IP ...
Managingip.com5d
McDermott capitalises on UPC strength to land DLA Piper partner
Strength at the Unified Patent Court was among the factors that drew a life sciences patent litigator to join McDermott Will ...